Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy

NCT00530569 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.

NCT NCT00530569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy
Lead sponsor
Alberta Health services
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2007
Completion date
Not reported
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer